Popular Articles

PhRMA's Tally: $40 Million To Lobby On Health Care
NPR reports on one of the most powerful players in health care: the Pharmaceutical Research and Manufacturers of America, or PhRMA. In addition to spending $40 million, PhRMA alone has 29 people lobbying for it and has "hired 45 different Washington, D.C., lobbying firms to represent it in those three months of the second quarter."

Data Shows Incisionless Procedure Reverses Weight Gain
Patients who have regained weight after gastric bypass surgery now have access to an incisionless procedure that appears highly effective at reversing weight gain, according to data presented at the annual meeting of the American Society of Metabolic and Bariatric Surgeons. Santiago Horgan, MD, professor of surgery and director of the Center for the Treatment of Obesity at UC San Diego, presented six-month outcomes from a national registry of 116 patients who underwent the procedure, known as ROSE (Restorative Obesity Surgery, Endolumenal).
News of the day
Reducing P38MAPK Levels Delays Aging Of Multiple Tissues In Lab Mice
In the new issue of the Developmental Cell journal, a team of scientists at Singapore"s Agency for Science, Technology and Research (A*STAR) and the University of North Carolina School of Medicine at Chapel Hill, report research findings about the molecular mechanisms behind the aging process, which has up till now been poorly understood, that offer the possibility that a novel, pharmacological approach could be developed to combat age-related disorders.
Mental Health

High IQ Is No Help For Those With ADHD, Yale Researchers Find

Superior intelligence is no defense against the effects of attention deficit and hyperactivity disorder, Yale researchers have found. About three of four ADHD individuals with an IQ of more than 120 - a score that ranks them in the top nine percent of the U.S. population - showed significant impairments in memory and cognitive tests when compared to people with similar IQ"s who do not suffer from the disorder, according to the researchers. The report, to be published in the September print edition of the Journal of Attention Disorders, is now available online. "Many of these people are told they can"t be suffering the loss of executive function (the ability to plan and carry out many day-to-day tasks) from ADHD because they are too smart,"" said Thomas E. Brown, assistant professor of psychiatry at the Yale School of Medicine and lead author of the study. The high-IQ, ADHD group lacked self-management skills and the ability to focus. They tended to procrastinate and be forgetful and had difficulty in harnessing their talent to complete many daily tasks, the study found. In fact, 73 percent of the ADHD population showed significant deficits in five or more of the eight measures of executive function. "Each of these individuals might be compared to a symphony orchestra of very talented musicians who cannot produce adequate symphonic music because the orchestra lacks an effective conductor," the authors wrote. Philipp C. Reichel and Donald M. Quinlan of Yale are co-authors of the paper. Yale University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):